Notice of AGM | 18-Nov-2024 | 07:00 | RNS |
Holding(s) in Company | 11-Oct-2024 | 17:30 | RNS |
Sale of Treasury Shares | 09-Oct-2024 | 17:45 | RNS |
Half-year Report | 25-Sep-2024 | 07:00 | RNS |
Consultancy Agreement | 02-Sep-2024 | 14:30 | RNS |
Director/PDMR Shareholding | 15-Jul-2024 | 07:00 | RNS |
Directorate Change | 15-Jul-2024 | 07:00 | RNS |
Annual Financial Report | 28-Jun-2024 | 07:00 | RNS |
Holding(s) in Company | 23-Jan-2024 | 07:00 | RNS |
Result of AGM | 01-Dec-2023 | 12:00 | RNS |
Notice of AGM | 07-Nov-2023 | 09:15 | RNS |
Interim Results | 28-Sep-2023 | 07:00 | RNS |
Summary Results of Phase II Study for Orenetide | 31-Aug-2023 | 07:00 | RNS |
Annual Financial Report | 30-Jun-2023 | 07:00 | RNS |
Update on Completion Timelines for Phase II Study | 12-Jun-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1.70p |
Change Today | -0.100p |
% Change | -5.56 % |
52 Week High | 1.92 |
52 Week Low | 0.55 |
Volume | 218,476 |
Shares Issued | 88.46m |
Market Cap | £1.50m |
Beta | 0.20 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:22 | 200,476 @ 1.63p |
08:11 | 18,000 @ 1.71p |
You are here: research